Quick Answer
First-generation antihistamines (Benadryl/diphenhydramine) cause significant sedation, anticholinergic effects (dry mouth, urinary retention, constipation), and cognitive impairment. Second-generation antihistamines (Zyrtec, Claritin) have much milder side effect profiles — primarily mild drowsiness in 2–15% of users. Third-generation fexofenadine (Allegra) has the fewest side effects of any OTC antihistamine, with rates equal to placebo in clinical trials.
Key Takeaways
- →First-generation antihistamines cause significant sedation AND anticholinergic effects — a distinct disadvantage
- →Second-generation antihistamines (cetirizine, loratadine) have minimal anticholinergic burden and low sedation
- →Fexofenadine (Allegra) has side effects statistically equal to placebo — the safest side effect profile
- →Diphenhydramine is Beers-listed for adults 65+ due to anticholinergic risk of falls, confusion, urinary retention
- →Never use alcohol with first-generation antihistamines — combined CNS depression is clinically dangerous
Why Side Effect Profiles Differ So Much
The dramatic difference in side effects between antihistamine generations comes down to two molecular properties: CNS penetration and receptor selectivity. First-generation antihistamines are lipophilic, small molecules that readily cross the blood-brain barrier and block not only H1 receptors but also muscarinic acetylcholine receptors (causing anticholinergic effects), alpha-adrenergic receptors, and serotonin receptors — producing a broad and often unwanted pharmacological footprint. Understanding allergy symptoms and how they're treated helps contextualize these trade-offs.
Second and third-generation antihistamines are selectively engineered to be substrates for P-glycoprotein (an efflux pump at the blood-brain barrier) and to have higher molecular weight and lower lipophilicity — all of which minimize CNS penetration. They are also more selective for H1 receptors, producing fewer off-target receptor effects. The result is antihistamine efficacy equivalent to first-generation agents for peripheral symptoms (skin, nose, eyes) with dramatically reduced CNS and anticholinergic side effects.
Side Effect Comparison by Drug
| Drug | Sedation | Dry Mouth | Urinary Retention | Headache | Weight Effect |
|---|---|---|---|---|---|
| Diphenhydramine (Benadryl) | High (>50%) | Yes | Yes (especially in men 50+) | Uncommon | Possible |
| Chlorpheniramine | High | Yes | Yes | Uncommon | Possible |
| Cetirizine (Zyrtec) | Low (~10–15%) | Rare | No | ~10% | Possible (small) |
| Levocetirizine (Xyzal) | Low (~10–15%) | Rare | No | ~8% | Possible (small) |
| Loratadine (Claritin) | Very low (~2–4%) | Rare | No | ~12% | Low risk |
| Fexofenadine (Allegra) | Equal to placebo | Rare | No | ~11% | Minimal |
Anticholinergic Effects in Detail
The anticholinergic side effects of first-generation antihistamines are caused by blockade of muscarinic acetylcholine receptors. These effects include: dry mouth (xerostomia), blurred vision (mydriasis and cycloplegia), urinary retention (especially problematic in men with benign prostatic hyperplasia), constipation, tachycardia, and in severe cases, confusion and delirium. The mnemonic often used to remember anticholinergic effects is: "dry as a bone, blind as a bat, red as a beet, hot as a hare, mad as a hatter, full as a flask."
Second-generation antihistamines have minimal muscarinic receptor affinity and therefore do not produce clinically meaningful anticholinergic effects at standard doses. For patients who need daily antihistamines and have risk factors for anticholinergic toxicity (BPH, glaucoma, dementia, advanced age), second-generation antihistamines are strongly preferred. For the complete picture of allergy treatment and medication selection, see our treatment hub.
Special Populations: Enhanced Side Effect Risk
Older Adults (65+)
The American Geriatrics Society Beers Criteria explicitly lists diphenhydramine, hydroxyzine, and other first-generation antihistamines as medications to avoid in older adults. The anticholinergic burden contributes to falls (due to sedation and confusion), urinary retention requiring catheterization, constipation leading to fecal impaction, and delirium — all of which are associated with serious clinical outcomes in the elderly. Second-generation antihistamines are preferred in this population.
Drivers and Safety-Sensitive Workers
Diphenhydramine impairs driving performance to an extent comparable to legal alcohol intoxication. Multiple simulator and on-road studies confirm impaired lane-keeping, reaction time, and divided attention with first-generation antihistamines. Fexofenadine and loratadine have the best documented driving safety profiles among antihistamines. See our Zyrtec vs Claritin vs Allegra guide for sedation comparison detail.
Pregnancy
Loratadine and cetirizine are the most studied antihistamines in pregnancy and have large safety datasets. Fexofenadine has less human pregnancy data but is FDA category B. First-generation antihistamines should generally be avoided, especially near delivery when neonatal sedation and withdrawal-like effects have been reported. All antihistamine use during pregnancy should be discussed with a healthcare provider.
Patients with BPH or Glaucoma
First-generation antihistamines are contraindicated in patients with closed-angle glaucoma (anticholinergic effects raise intraocular pressure) and in men with significant BPH (urinary retention risk). Second-generation antihistamines are safe in both conditions. If eye drops containing antihistamines are used, they should be administered with the lacrimal duct occluded to minimize systemic absorption.
When Side Effects Warrant Stopping or Switching
Mild drowsiness from cetirizine often improves after a few days as the body adapts, or by switching to evening dosing. If headache is persistent with one antihistamine, switching to a different second-generation agent often resolves it. Significant side effects — urinary retention, confusion, palpitations, or severe drowsiness — warrant stopping the medication and consulting a healthcare provider. For complete treatment options beyond antihistamines, and our OTC allergy medications guide and antihistamines comparison provide further context. If allergy testing reveals specific triggers, allergen immunotherapy may reduce medication dependence long-term.